Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
282
-
Total 13F shares, excl. options
-
65.2M
-
Shares change
-
+1.45M
-
Total reported value, excl. options
-
$6.19B
-
Value change
-
+$140M
-
Put/Call ratio
-
0.97
-
Number of buys
-
150
-
Number of sells
-
-111
-
Price
-
$94.86
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q1 2024
339 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q1 2024.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 282 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.2M shares
.
Largest 10 shareholders include BlackRock Inc. (6.45M shares), VANGUARD GROUP INC (6.31M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.25M shares), FMR LLC (5.17M shares), WELLINGTON MANAGEMENT GROUP LLP (4.18M shares), Rock Springs Capital Management LP (2.5M shares), STATE STREET CORP (2.19M shares), PICTET ASSET MANAGEMENT Holding SA (1.86M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.71M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.37M shares).
This table shows the top 282 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.